mFOLFOXIRI for neoplasm, residual

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Trial registered. A trial in people is registered. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 22 Jun 2022: Trial registered, NCT05427669

The trials

NCT05427669: Adjuvant mFOLFOXIRI vs. mFOLFOX6 in MRD Positive Stage II-III Colorectal Cancer (AFFORD)

State
Not started
Phase
Phase 3
People
340 planned
Started
9 Oct 2022
Primary completion
1 Jul 2025
Arms
mFOLFOXIRI
Results
None posted
  1. 22 Jun 2022: Trial registered

How the status changed

  1. 19 Nov 2026: First set: Trial registered

About the treatment

Kind of treatment: Drug.

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.